Jessica Grossman

Jessica Grossman

Company: IgGenix, Inc.

Job title: Chief Executive Officer


Developing Antibody-Based Approaches to Reduce Downstream Allergenic Responses 2:00 pm

Re-engineering Ig-E antibodies to directly block the molecules in underlying disease Potential future use of monoclonal antibody therapeutics to address specific allergies with high affinity Effects of addressing key allergens directly on safety and mechanism of actionRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.